Serum Institute of India was on the verge of signing a billion-dollar agreement with a clutch of marquee global investors last year but withdrew at the last minute even as it struggled to scale up production of COVID-19 vaccines due to an apparent lack of funds, said two people directly aware of the matter.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in